APA način citiranja

Lim, B., Scicchitano, A., Beachler, C., Gusani, N., Sarwani, N., Yang, Z., . . . El-Deiry, W. S. (2013). FOLFIRI plus dulanermin (rhApo2L/TRAIL) in a patient with BRAF-mutant metastatic colon cancer. Landes Bioscience.

Čikaški stil citiranja

Lim, Bora, et al. FOLFIRI Plus Dulanermin (rhApo2L/TRAIL) in a Patient With BRAF-mutant Metastatic Colon Cancer. Landes Bioscience, 2013.

MLA način citiranja

Lim, Bora, et al. FOLFIRI Plus Dulanermin (rhApo2L/TRAIL) in a Patient With BRAF-mutant Metastatic Colon Cancer. Landes Bioscience, 2013.

Upozorenje: Ovi citati možda nisu uvijek 100% točni.